Established in 2011, Aimei Kanghuai Biopharmaceutical (Jiangsu) Co., Ltd. (“AIM Kanghuai”) is a subsidiary of AIM Vaccine Co., Ltd. and one of the only two domestic manufactures of inactivated hepatitis A vaccine. With a registered capital of RMB 360 million, the Company is located at the China Medical City of Taizhou, Jiangsu Province, occupying nearly 18711㎡ of land with a total floor area of about 60000㎡. AIM Kanghuai specializes in viral vaccine platform technologies.
In accordance with AIM Vaccine’s mission of “producing good vaccines for the health of the people,” AIM Kanghuai aims to give full play to the whole-industry-chain advantages of the group, inherit the hepatitis A production technology of the Institute of Medical Biology, Chinese Academy of Medical Sciences, and utilize the industrial cluster of China Medical City and various preferential policies, to develop biological products such as new vaccines and create a high-level industrial production platform targeting the prevention and control needs of major communicable diseases at home and abroad.
So far, AIM Kanghuai has completed the construction of its inactivated hepatitis A vaccine production line, passed the national GMP certification, equipped itself with cell factory and microcarrier cell fermentation culture technologies for the mass production of biological products, and obtained a new drug certificate issued by the National Medical Products Administration on April 2, 2015 as well as a GMP certificate issued by the National Medical Products Administration for its inactivated hepatitis A vaccines (human diploid cell) of all specifications in January 2016.
Looking into the future, AIM Kanghuai will promote the industrialization of its vaccines under development with the operation management mechanism of modern enterprise, integrate innovation and R&D with high-efficiency production, make new contribution to the prevention and control of major communicable diseases at home and abroad, and usher in a new era of the global cause of human health.
Mission: Producing good vaccines for the health of the people
Vision: Leading the global vaccine industry
Core values: innovation, synergy, empowerment, compliance